Clinical Trial Update: GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

View source ↗

Summary

A ClinicalTrials.gov entry for GRAfT 2.0, a multimodal prospective study to define mechanisms and clinical features of acute and chronic rejection after lung tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Lung Disease
• Lung Transplant Rejection

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Transplant, End Stage Lung Disease | Status: NOT_YET_RECRUITING